|By PR Newswire||
|August 16, 2014 03:09 PM EDT||
OTTAWA, Aug. 16, 2014 /CNW/ - Apotex, in consultation with Health Canada, is recalling one lot (KY6601) of Apo-Mycophenolic Acid due to a package labelling error. The product is used to prevent organ rejection in patients receiving a kidney transplant.
The French statement on the outer carton indicates that each tablet contains 180 mg of the medicine. The actual tablets in the package contain the correct strength of 360 mg. The rest of the carton, the leaflets, the blister labels and the dosing instructions all contain the appropriate labelling for the 360 mg strength.
In the unlikely event that a patient takes a higher dose due to the labelling error, it could result in over-suppression of the immune system and may lead to increased risk of infection causing a serious or fatal outcome. Other symptoms include blood abnormalities and stomach problems.
As of August 15, 2014, no adverse reactions related to this issue had been reported to either Apotex or to Health Canada.
Patients taking Apo-Mycophenolic Acid should check the label and if there is any confusion about the dose, they should consult with their pharmacist. Patients should also consult with their healthcare practitioners should they have any concerns.
Health Canada will monitor Apotex's recall and will inform Canadian should new safety information arise.
Apo-Mycophenolic Acid (front package label)
SOURCE Health Canada
Nov. 21, 2014 12:30 PM EST Reads: 593
Nov. 21, 2014 12:30 PM EST Reads: 538
Nov. 21, 2014 12:00 PM EST Reads: 737
Nov. 20, 2014 11:45 PM EST Reads: 1,198
ARMONK, N.Y., Nov. 20, 2014 /PRNewswire/ -- IBM (NYSE: IBM) today announced that it is bringing a greater level of control, security and flexibility to cloud-based application development and delivery with a single-tenant version of Bluemix, IBM's
Nov. 20, 2014 10:30 PM EST Reads: 1,115
Nov. 20, 2014 09:15 PM EST Reads: 1,150
Nov. 20, 2014 09:00 PM EST Reads: 1,295
Nov. 20, 2014 07:30 PM EST Reads: 1,300
Nov. 20, 2014 07:00 PM EST Reads: 1,207
Nov. 20, 2014 07:00 PM EST Reads: 1,054
Nov. 20, 2014 06:00 PM EST Reads: 1,123
Nov. 20, 2014 04:45 PM EST Reads: 832
Nov. 20, 2014 01:00 PM EST Reads: 1,371
The Internet of Things is not new. Historically, smart businesses have used its basic concept of leveraging data to drive better decision making and have capitalized on those insights to realize additional revenue opportunities. So, what has changed to make the Internet of Things one of the hottest topics in tech? In his session at @ThingsExpo, Chris Gray, Director, Embedded and Internet of Things, discussed the underlying factors that are driving the economics of intelligent systems. Discover ...
Nov. 20, 2014 12:30 PM EST Reads: 1,646